Cresset Asset Management LLC Has $4.56 Million Stake in Core Scientific, Inc. $CORZ

Cresset Asset Management LLC lowered its position in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 59.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 254,379 shares of the company’s stock after selling 371,878 shares during the period. Cresset Asset Management LLC owned 0.08% of Core Scientific worth $4,564,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Harvest Portfolios Group Inc. increased its position in Core Scientific by 81.9% during the 2nd quarter. Harvest Portfolios Group Inc. now owns 134,895 shares of the company’s stock worth $2,303,000 after buying an additional 60,746 shares during the period. ORG Wealth Partners LLC boosted its position in shares of Core Scientific by 1.8% in the third quarter. ORG Wealth Partners LLC now owns 7,290,481 shares of the company’s stock valued at $130,791,000 after acquiring an additional 128,284 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH boosted its position in shares of Core Scientific by 39.9% in the third quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 452,806 shares of the company’s stock valued at $8,123,000 after acquiring an additional 129,133 shares during the period. Prudential Financial Inc. grew its stake in shares of Core Scientific by 1,326.9% in the second quarter. Prudential Financial Inc. now owns 199,630 shares of the company’s stock valued at $3,408,000 after acquiring an additional 185,640 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd grew its stake in shares of Core Scientific by 87.4% in the third quarter. Y Intercept Hong Kong Ltd now owns 668,435 shares of the company’s stock valued at $11,992,000 after acquiring an additional 311,813 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages have weighed in on CORZ. LADENBURG THALM/SH SH dropped their price objective on shares of Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a research note on Tuesday. BTIG Research upgraded shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Tuesday, January 6th. Zacks Research raised shares of Core Scientific from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 13th. Keefe, Bruyette & Woods lifted their price target on shares of Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a research report on Tuesday, January 27th. Finally, Citigroup upgraded Core Scientific from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 18th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.84.

Core Scientific Stock Down 7.1%

CORZ opened at $14.86 on Friday. The stock has a market capitalization of $4.69 billion, a price-to-earnings ratio of 12.70 and a beta of 6.87. Core Scientific, Inc. has a twelve month low of $6.20 and a twelve month high of $23.63. The company has a 50-day simple moving average of $17.27 and a 200 day simple moving average of $16.95.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. Core Scientific’s quarterly revenue was down 16.0% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.69) earnings per share. Sell-side analysts anticipate that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

More Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Core Scientific secured a $1.0 billion loan from Morgan Stanley to fund its AI pivot and provide liquidity for growth initiatives — this materially reduces near‑term financing risk and supports capital spending for compute/AI activities, which is constructive for valuation if execution follows. Core Scientific secures $1 billion loan
• Positive Sentiment: HC Wainwright reiterated a “Buy” rating, lifted FY‑2026 estimates (now $0.33 EPS from $0.16 previously) and published quarterly EPS forecasts with a $25 price target — analyst upgrade increases upside narrative and can buoy investor sentiment. HC Wainwright Reiterates Buy
• Positive Sentiment: Needham & Company upgraded Core Scientific — another independent analyst endorsement that may attract buyers or support a rerating if momentum continues. Needham upgrades CORZ
• Neutral Sentiment: Short‑interest reports show 0 shares and produce NaN changes and a 0.0 days‑to‑cover figure — this appears to be a data anomaly and is not reliable as a signal of bearish positioning. (No actionable short‑squeeze implications absent corrected data.)
• Negative Sentiment: Ladenburg Thalmann/SH lowered expectations for CORZ, which could weigh on sentiment and increase selling pressure among investors focused on near‑term fundamentals. Ladenburg lowers expectations
• Negative Sentiment: Recent results were mixed: Core beat Q4 EPS but missed revenue estimates and saw year‑over‑year revenue decline — ongoing top‑line pressure means the market remains sensitive to execution risk on the AI pivot and margin recovery, which can cap near‑term upside.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.